PRIMER · AGENTIC AI · 8 min
Agentic AI in Healthcare
The 2026 industry trend reports (Deloitte, Becker's, Wolters Kluwer) put agentic AI at the top of the healthcare-AI agenda. The marketing has run ahead of the deployment reality: 69% of healthcare organizations are using generative AI; only 22% are using AI agents. This primer explains what agentic AI actually is, where it is safely deployable today, where it isn't yet, and what governance the trend requires before the next round of vendor demos.
61% of healthcare organizations are building or have budgeted for agentic AI initiatives per Deloitte 2026.
Only 22% have agents in production. The build-vs-deploy gap is the largest in any AI category.
98% of healthcare executives expect at least 10% cost savings from agentic AI over 2-3 years; 37% expect ≥20%.
The single most-cited barrier to scaling agentic AI in healthcare: governance / autonomy posture, ahead of technical capability.
What "agentic" actually means
The term gets used loosely. For a buyer, three precise distinctions matter:
Generates output in response to one prompt. The clinician asks; the model answers. AI scribes are assistants in this strict sense — they produce a draft note from one audio capture.
Generates output in a conversational loop with the human. Microsoft Copilot, Dragon Copilot, similar. The human remains the decider; the AI is iteratively helpful.
Plans and executes multi-step tasks with limited human input. Calls tools (APIs, EHR functions, external services). Decides what to do next between steps. Loops until a goal is met or a stop condition fires.
The buyer-relevant distinction: agents take actions. They modify state — populate an order, send a message, schedule an appointment, file a referral, query a system, write to a chart. Assistants and copilots produce text that humans then act on. The autonomy gap is where the safety and governance conversation lives.
Where agentic AI is safely deployable today
The 2026 production deployments cluster in three operational categories where the failure modes are recoverable and the human can stay in the loop without losing the autonomy benefit:
- checkPatient scheduling and reminders. Multi-step booking workflows (check insurance, find a matching specialty + provider, find a slot, send confirmation, send reminder). Failure mode: a missed booking. Recoverable.
- checkPrior authorization drafting. Pulls visit context, drafts the prior-auth packet, routes for clinician approval. The agent does the prep; the clinician approves. The published reference is Abridge's January 2026 Availity partnership for real-time prior-auth drafting.
- checkRevenue cycle automation. Coding suggestions, claims-error remediation, denials work-queue triage. Failure mode: a miscoded claim that the existing RCM review catches. Recoverable, high ROI, lower clinical risk.
- checkInternal knowledge assistants with tool use. "Find me the latest formulary policy on X, summarize, surface the version date." The agent retrieves, summarizes, cites; the human verifies. Low risk because the output is text plus citations the human can verify.
Where agentic AI is not safely deployable yet
Three categories the 2026 trend reports identify as still in pilot / governance / research mode, where buyer hype has run ahead of deployment reality:
- closeAutonomous clinical decisions. No serious deployment lets an agent decide diagnosis, treatment, or management. The published evidence on hallucinations (1.47% major) and omissions (3.45%, clustering in HPI) makes autonomous clinical decisions a non-starter under current model quality. Decision support, yes; autonomous decisions, no.
- closeDirect patient-facing clinical triage without escalation. Symptom-checker agents that route patients without a clinician-in-the-loop escalation path. The liability and equity-disparity risks are unresolved. Triage-with-escalation is fine; triage-as-final-step is not.
- closeMulti-system actions without write controls. An agent with the keys to multiple systems (EHR + scheduling + pharmacy + lab) and the authority to write across them is the highest-blast-radius failure shape. Production deployments segment the agent's write scope tightly.
The governance that agents require
An assistant or copilot's worst-case failure is "the human reads the bad draft and acts on it." An agent's worst-case failure is "the agent did something the human didn't review." The governance posture has to scale to that gap. Four controls every agentic deployment should ship with:
- check1. Tool inventory + scope limits. Every action the agent can take is enumerated. Each has a defined scope (which records / values / endpoints). The agent cannot invent new tools at runtime.
- check2. Human approval gates for high-stakes actions. Read-only retrieval and summarization can run autonomously; any write that touches a chart, an order, a billing claim, or a patient communication requires a clinician approval step.
- check3. Breakpoints and state snapshots. The agent can pause at named decision points and emit a snapshot the human reviews before resumption. Haystack's 2026 agent features explicitly support this pattern.
- check4. Differential audit log. Every action with model decision rationale, tool call, input, output, and approver. The audit log for an agent has to be richer than for an assistant because the auditable surface is wider.
How agents fit into the WalledCare workflow categories
The five WalledCare workflow categories shift in different ways under the agentic lens:
| Workflow | 2026 agentic shape | Risk class |
|---|---|---|
| AI Scribes | Mostly assistant + copilot; some prior-auth drafting agents (Abridge / Availity) at the edge. | Low (text production with clinician sign-off). |
| Document Q&A | Agent retrieves across sources, synthesizes, cites; human verifies before action. | Low when read-only; medium when the agent acts on the synthesis. |
| Private medical search | Often agentic — multi-source retrieval, federation across local and licensed corpora, ranking, synthesis. Same risk profile as Document Q&A. | Low when read-only. |
| Discharge summaries | Agent pulls chart context, drafts the discharge note + medication reconciliation + patient-facing summary, routes for clinician review. | Medium — medication reconciliation is high-stakes; clinician approval gate mandatory. |
| Handoff tools | Agent reads 12 hours of chart, drafts SBAR / I-PASS, surfaces pending items. Read-mostly; write surface is the handoff note itself. | Medium-high — handoff is a documented high-risk surface; review gates non-negotiable. |
| Scheduling / RCM / prior auth | Most agentic 2026 deployments concentrate here. Write actions are recoverable; ROI is high; clinical-safety risk is low. | Low-medium. |
What this means for procurement in 2026
Three procurement moves a hospital should make as agentic-AI vendor pitches arrive:
- check1. Force the vendor to describe the agent's write scope in writing. Which actions, which systems, which records, under what approval. The vague answer is the warning signal.
- check2. Demand the differential audit log artifact. Vendor's audit log for an agent should show the planning trace, not just the final action. Ask for a sample export from a current customer.
- check3. Start with operational workflows, not clinical decisions. Scheduling, prior auth, RCM, internal knowledge — proven 2026 surfaces. Avoid vendors whose pitch leads with autonomous clinical decisions; the safety story isn't there yet.
Where this fits in the WalledCare directory
This primer pairs with the safety reference (which covers the model-quality floor agents inherit), the privacy officer's guide (the audit-log artifact agents amplify), and the Haystack profile (the most operationally mature open-source agent framework, with explicit 2026 breakpoint and state-snapshot support).